Merit Medical (MMSI) announced the appointment of Martha Aronson as Merit’s new president and CEO, effective October 3. Fred Lampropoulos will remain as chairman of the board, president and CEO of Merit through October 3. Upon Aronson’s appointment, Lampropoulos will continue to serve as chairman of the board. Aronson was the executive VP and president of global healthcare for Ecolab (ECL).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical CEO sells $1.93M shares of shares
- Positive Outlook for Merit Medical Systems Amid Tariff Reductions and Resilient Growth
- Merit Medical price target raised to $110 from $106 at Piper Sandler
- Merit Medical price target raised to $112 from $108 at Canaccord
- Merit Medical price target raised to $108 from $106 at Wells Fargo